Overview of Cytostatic Drug Prescribing for Inpatient Cancer Patients at RSUD Tarakan July-December 2021 Period
Article Sidebar
Main Article Content
Abstract
Chemotherapy, which uses cytostatic chemical medicine to kill or halt the growth of cancer cells, is one kind of treatment for cancer. In order to treat cancer, a variety of medication classes and delivery systems are used. The technique of study is retrospective and descriptive. Data collection for inpatients with cancer at RSUD Tarakan utilizing retrospective medical record data for the months of July through December 2021. This study aims to determine the demographic features of patients diagnosed with suspected cancer; the type of cancer most commonly suffered by patients; types, classes and combinations between cytotoxic drugs and combinations of therapeutic classes. Seventy patients were included in the study as research subjects who met the requirements. According to the study, there were 24 men (34.29 %) and 46 women patients. Twenty patients (or 28.57 %) are in the age range of 45 to 54. Breast cancer, which affected up to 16 people, was the most prevalent type of cancer. Alkalitor was the most commonly prescribed class of cytostatic medicines based on mechanism of action, with 54 prescriptions (32,53 %) written. Paclitaxel was the most commonly prescribed cytostatic medication, with 24 prescriptions (14,46 %). Fluorouracil + Irinotekan was the most commonly prescribed cytostatic medication combination, with 13 prescriptions (27.66 %). Dexamethasone was the most commonly prescribed combination of other therapeutic classes with cytostatic medicines, with 57 prescriptions (27,54 %).
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
WHO. International Agency for Research on Cancer. WHO Chron. 2020;23(7).
CancerHelps T. Stop Kanker. PT. AgroMedia Pustaka. 2010. 204 p.
BPPK. Laporan Nasional RISKESDAS 2018. Vol. 1, Kementerian Kesehatan RI. 2018. 581 p.
BPPK. Riset Kesehatan Dasar 2013. Badan Penelitian dan pengembangan Kesehatan Kementerian Kesehatan RI; 2013. 306 p.
Hardjono S, Siswandono, Diah N wahyuni. Obat Antikanker. Surabaya: Airlangga University Press; 2016. 106 p.
Kelvin JF. 100 Tanya Jawab mengenai Gejala Kanker dan Efek Samping Pengobatan Kanker. Edisi 2. Tyson, Leslie B. Jakarta Indeks; 2011.
Rikomah SE. Farmasi Klinik. 1st ed. Deepublish; 2018. 241 p.
Firsty Y, Lantika O, Rusli R, Ayu WD, Farmasi F, Mulawarman U, et al. Kajian Pola Pengobatan Penderita Kanker Serviks Pada Pasien Rawat Inap Di Instalasi Rsud Abdul Wahab Sjahranie Periode 2014-2015. Jurnal Sains dan Kesehatan. 2018;1(8):448–55.
Wahyuni D, Huda N, Utami GT. Studi Fenomenologi: Pengalaman Pasien Kanker Stadium Lanjut Yang Menjalani Kemoterapi. Jom. 2015;2(2):1041-1047 p.
Mariani KS. Profil Penggunaan Obat Sitostatika Pada Pasien Kanker Rawat Inap yang Menjalani Kemoterapi di RSUD Prof. Dr. W. Z. Johannes Kupang Tahun 2018. 2018;
Ardhiansyah AO. Deteksi Dini Kanker. Purwanto H, editor. Surabaya: Airlangga University Press; 2019. 100 p.
Tjay TH, Rahardja K. Obat obat penting edisi 7. Vol. 53, Pt Elex Media Komputindo. 2015. 522 p.
Ariani, Sofi. Stop kanker. Yogyakarta: Istana Media; 2015. 280 p.
Budhy TI. Mengapa Terjadi Kanker. Surabaya: Airlangga University Press; 2019.
Offiah G, Hill A. Principles of Surgery. 10th ed. Rcsi Handbook of Clinical Surgery for Finals. United States: McGraw-Hill Education; 2021. 1-30 p.
Panigroro S, Hernowo BS, Purwanto H. Panduan Penatalaksanaan Kanker Payudara (Breast Cancer Treatment Guideline). Jurnal Kesehatan Masyarakat. 2019;4(4):1-50 p. Available from: http://kanker.kemkes.go.id/guidelines/PPKPayudara.pdf
Nafrialdi, Gan S. Farmakologi dan Terapi. In: Gan S, Setiabudy R, Nafrialdi, Elysabeth, editors. Antikanker. 5th ed. Badan Penerbit FKUI Jakarta; 2007.
Abdulmuthalib. Buku Ajar Ilmu Penyakit Dalam edisi 6. In: Setiati S, Alwi I, Simadibrata M, Setyohadi B, editors. InternaPublishing; 2014. p. 1423 p.
Skach W, Daley CL, Forsmark CE. Penuntun Terapi Medis. In: Kemoterapi Kanker & Kedaruratan Onkologis. XVII. Penerbit Buku Kedokteran; 2008.
Firmana D. Keperawatan Kemoterapi. Susila A, Utami T, editors. Salemba Medika; 2017. 208 p.
Sani K F. Metodologi Penelitian Farmasi Komunitas dan Eksperimental. 1st ed. Deepublish; 2016. 186 p.
Rachmawati AS. Prevalensi Kanker di Rumah Sakit Jasa Kartini Kota Tasikmalaya Tahun 2018. J Kesehat Komunitas Indones. 2020;16(1):119–26.
Sidauruk JTS. Hubungan Usia Dengan Estrogen Receptor Pada Penderita Kanker Payudara di RSUD Dr. Pirngadi Medan Tahun 2018. Nommensen J Med. 2020;6(1):1–4.
Yulianti I, Santoso H, Sutinigsih D. Faktor-Faktor Risiko Kanker Payudara (Studi Kasus Pada Rumah Sakit Ken Saras Semarang). Jurnal Kesehatan Masyarakat Univ Diponegoro. 2016;4(4):401–9.
Toffoli G, Cecchin E, Gasparini G, D’Andrea M, Azzarello G, Basso U, et al. Genotype-driven phase I study of irinotecan administered in combination with fluorouracil/leucovorin in patients with metastatic colorectal cancer. J Clin Oncol. 2010;28(5):866–71.
Lilyawati SA, Fitriani N, Prasetya F. Proceeding of Mulawarman Pharmaceuticals Conferences. Proceeding Mulawarman Pharm Conf [Internet]. 2019;(April 2021):135–8.
Cartika, harpolia, Cartika, H., Yusmaniar, Y., Hakim Kurniawan, A., Hasbi, F., & Suryani, D. (2022). Profile of Prescribing COVID -19 Drug Therapy in Inpatients At Jakarta Haji Hospital. SANITAS: Jurnal Teknologi Dan Seni Kesehatan, 13(1), 1-12. https://doi.org/10.36525/sanitas.2022.1
Achmadi, N., Setiawan, Y., & Ayu Purwati, A. (2021). An Overview Knowledge and Usage of Herbal Medicines during The COVID-19 Pandemic by Students of Poltekkes Kemenkes Jakarta II. SANITAS: Jurnal Teknologi Dan Seni Kesehatan, 12(2), 106-114. https://doi.org/10.36525/sanitas.2021.10